XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Market Cap	$431.53M	P/E Ratio	27.14
52W High	$39.92	52W Low	$18.35
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-63.8%	52W Position	62.1%
Overall Score	54	Value Score	50
Quality Score	--	Technical Score	58

EPS Current Est	$1.17	EPS Next Est	$0.59
EPS Growth Est	-49.6%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	XOMA	$31.75	-0.25%	44.95K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	XOMA	$31.75	-0.3%	44.95K
3
4
5
6

XOMA

XOMA

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get XOMA Royalty Corporation Data in Excel

Get XOMA Royalty Corporation Data in Excel